There is no single test that proves IBS. Doctors usually recognise it from a typical symptom pattern after looking for other causes. Blood tests and sometimes stool tests help check for anaemia, inflammation, coeliac disease, or infection. A camera test of the bowel is not needed for everyone. Results must be interpreted with your history and examination.
People often expect a scan or a laboratory result that can “confirm” irritable bowel syndrome. In practice, IBS is identified from a recognised pattern of abdominal pain linked to bowel habits, after a clinician has checked for features that point to another condition. Tests are chosen to answer a specific question, not to run through every possible investigation.
That approach matters because many digestive problems can look similar at first. Coeliac disease, bowel inflammation, infection, and, less often, other medical conditions may cause overlapping symptoms. Limited testing helps a doctor decide whether the picture fits IBS or whether something else needs attention first. A fuller overview of how clinicians put the whole picture together is available in the guide to how IBS is diagnosed.
Why testing is usually limited
Major clinical guidelines support a positive diagnosis of IBS when symptoms are typical, examination is reassuring, and simple blood and stool tests do not point to another disease. The British Society of Gastroenterology advises that people presenting with IBS-type symptoms for the first time should have a full blood count, a blood inflammation marker such as C-reactive protein or erythrocyte sedimentation rate, coeliac serology, and, in younger adults with diarrhoea, a faecal calprotectin test to help exclude inflammatory bowel disease. The same guidance also states that clinicians should make a positive diagnosis after these checks if there are no alarm features.
The National Institute for Health and Care Excellence similarly recommends a small set of blood tests in people who meet symptom criteria: a full blood count, an inflammation marker, and antibody testing for coeliac disease. NICE guidance also lists investigations that are not needed simply to confirm IBS when the clinical picture is typical, including routine ultrasound, colonoscopy, thyroid testing, stool parasite testing, faecal occult blood testing, and hydrogen breath tests.
In other words, normal results do not “create” the diagnosis on their own. They support a clinical judgement already based on your symptoms, how long they have been present, and what the examination shows. Recurring pain linked to stool form or frequency is described in more detail on the page about typical IBS symptoms.
A laboratory finding is information, not a label. A result that is higher than expected, lower than usual for that laboratory, or different from a previous result still has to be interpreted by a healthcare professional. Reference ranges vary between laboratories. Trends, symptoms, medicines, and medical history all matter more than any isolated number.
Blood tests commonly requested
A full blood count looks at red cells, white cells, and platelets. Doctors use it to check for anaemia or other blood changes that would be unexpected in uncomplicated IBS. Anaemia does not diagnose a specific bowel disease, but it may prompt a closer look for blood loss, nutrient problems, or another explanation.
C-reactive protein and erythrocyte sedimentation rate are general markers of inflammation in the body. They are not specific to the gut. When these markers are higher than the laboratory’s expected range, a clinician may consider infection, inflammatory bowel disease, or another inflammatory process, always in the light of symptoms. A result within the stated range does not rule out every other condition, and an unexpected result does not automatically mean IBS is the wrong explanation.
Coeliac antibody testing, usually a tissue transglutaminase antibody test, is often included because coeliac disease can mimic IBS, especially when diarrhoea is prominent. Guidelines from both NICE and the British Society of Gastroenterology include coeliac serology in the initial work-up. The blood test does not itself confirm coeliac disease. If the result is unexpected, a doctor may discuss further assessment, which can include small-bowel biopsy. People should keep eating gluten before coeliac blood testing unless a clinician has already given different advice, because avoiding gluten can make the test harder to interpret.
Thyroid blood tests are not part of the routine IBS panel in NICE recommendations. A clinician may still request them if the history raises a separate question, such as marked constipation, unexplained weight change, or other features that may be related to thyroid function.
Stool tests and what they can show
Stool tests are used most often when diarrhoea is a main feature or when a doctor wants to look for bowel inflammation. Faecal calprotectin measures a protein released by white blood cells in the gut. NICE recommends faecal calprotectin as an option to help distinguish inflammatory bowel disease from IBS in adults with recent lower gut symptoms when cancer is not the leading concern and agreed testing pathways are in place. That recommendation is about supporting a differential diagnosis, not about labelling IBS from a single stool result.
A calprotectin result that is higher than the laboratory’s reference range may suggest intestinal inflammation and often leads to further specialist assessment. A result in the expected range makes active inflammatory bowel disease less likely, but it still has to be read alongside symptoms. Laboratories use different methods and cut-off values, so only the requesting clinician can interpret the report for that person. This distinction between a functional bowel problem and inflammatory disease is also discussed in the comparison of IBS and inflammatory bowel disease.
Other stool studies may be used in selected situations. Microscopy and culture can look for infection. In some settings, including parts of southern Africa, clinicians may consider parasites when there has been relevant exposure, travel, unsafe water, or other risk factors. The World Gastroenterology Organisation notes that the need for stool studies and endoscopy should take account of local patterns of disease, including parasitosis. Its resource-sensitive cascade also reminds clinicians that not every person with IBS-type symptoms needs the same intensity of investigation.
Tests for hidden blood in the stool are not required to confirm IBS when symptom criteria are already met. A doctor may still use a faecal immunochemical test, or another blood-in-stool test, if age, symptom change, or local cancer-referral guidance makes that appropriate. That decision is about looking for another condition, not about grading IBS.
The table below summarises the tests most often discussed when IBS is being considered and the question each one is trying to answer. It is a guide to purpose, not a checklist for self-assessment.
| Test | What it may help a doctor assess |
|---|---|
| Full blood count | Whether there is anaemia or another unexpected blood change |
| CRP or ESR | Whether there is a general sign of inflammation in the body |
| Coeliac antibody blood test | Whether coeliac disease is a possible alternative explanation |
| Faecal calprotectin | Whether there is evidence of inflammation in the bowel |
| Stool microscopy or culture | Whether infection, including parasites in selected cases, may be present |
None of these investigations diagnoses IBS by itself. Unexpected results need professional interpretation, and a result within the laboratory range does not replace a careful history. Repeat testing is sometimes needed if symptoms change or if the first sample was difficult to interpret.
When a camera test or extra investigation is considered
Colonoscopy looks at the lining of the large bowel with a flexible camera and can take biopsies. It is not a standard test for every person with suspected IBS. The British Society of Gastroenterology states that there is no role for colonoscopy in IBS except where there are alarm features, or in selected people with diarrhoea and atypical features that raise the possibility of microscopic colitis.
A doctor is more likely to discuss endoscopy or imaging when symptoms start later in life, when there is unexplained weight loss, rectal bleeding, iron-deficiency anaemia, a mass, a strong family history of bowel disease or bowel cancer, or a clear change from the person’s usual pattern. Those warning features are outlined separately in the article on IBS red flags.
Further tests used only in selected cases can include assessment for bile acid diarrhoea after gallbladder surgery or with watery diarrhoea that does not fit the usual pattern, anorectal physiology testing when there is a suspected emptying problem, or upper endoscopy if coeliac disease or another small-bowel condition remains possible. Hydrogen breath testing for lactose intolerance or small-intestinal bacterial overgrowth is not recommended as a routine step in people with typical IBS symptoms.
Food-allergy panels are also not a standard way to diagnose IBS. If symptoms seem tightly linked to a particular food, a clinician or dietitian can discuss a supervised approach rather than an unsupervised battery of tests. Possible dietary and other triggers for IBS symptoms are a separate topic from laboratory diagnosis.
How clinicians read the whole picture
Doctors do not treat a test report in isolation. They look at the duration of symptoms, stool pattern, night-time symptoms, medicines, recent infection, surgery, family history, and findings on examination. A result that is different from a previous one may be more informative than a single value. If symptoms later change in character, limited tests may be repeated even after an earlier IBS diagnosis, because a new feature can deserve a fresh look.
The South African Gastroenterology Society has shared World Gastroenterology Organisation education for the public on what IBS is and how people can describe symptoms clearly to their doctor. That patient-facing programme sits alongside the clinical principle used internationally: name IBS when the pattern fits and basic tests are reassuring, then focus on management rather than an ever-longer list of investigations.
Care commonly begins with a general practitioner. Referral to a gastroenterologist may be discussed if symptoms are difficult to control, if test results need specialist interpretation, or if alarm features appear. That pathway varies with individual circumstances and local services. After the working diagnosis is clear, attention usually turns to symptom control, including the options described in the article on IBS treatment.
When it is sensible to seek medical review
Arrange a medical assessment if abdominal pain and a change in bowel habit have lasted for weeks to months, interfere with daily life, or leave you unsure whether the symptoms are new or familiar. Seek prompt care for rectal bleeding, black stools, unintentional weight loss, persistent vomiting, difficulty swallowing, a fever that does not settle, or a sudden change in bowel habit, especially later in adulthood.
Bring a simple record of stool form, frequency, and associated pain if you can. Mention travel, antibiotics, family history, and any previous results. Only a qualified healthcare professional can decide which tests, if any, are appropriate and what the reports mean for you.
Frequently Asked Questions
These questions address common concerns about the tests used when IBS is being considered. They are educational and do not replace personal medical advice.
Is there a blood test that can confirm IBS?
No. Blood tests used in this setting look for other conditions that can resemble IBS, such as anaemia, general inflammation, or coeliac disease. IBS is identified from the symptom pattern together with examination findings and selected test results. A normal blood test supports the clinical picture; it does not prove IBS on its own.
Do I need a colonoscopy to diagnose IBS?
Not usually. Colonoscopy is considered when there are warning features, when age or family history makes bowel examination appropriate, or when diarrhoea has atypical features that raise other possibilities. In many people with a typical history and reassuring basic tests, a camera test is not required to diagnose IBS.
What does a faecal calprotectin test show?
Faecal calprotectin can indicate whether there is inflammation in the bowel. Doctors may use it to help distinguish inflammatory bowel disease from IBS, particularly when diarrhoea is present. Laboratories use different reference ranges, and only a clinician can interpret the result alongside your symptoms and other findings.
Why might tests be repeated after an IBS diagnosis?
Repeat testing may be considered if symptoms change, if new warning features appear, or if an earlier result was unclear. A previous IBS diagnosis does not mean every future symptom is automatically IBS. Trends over time and a change from your usual pattern often matter more than a single report.
References
- NICE. Irritable bowel syndrome in adults: diagnosis and management (CG61), recommendations on diagnostic tests
- British Society of Gastroenterology. Guidelines on the management of irritable bowel syndrome. Gut. 2021
- NICE. Faecal calprotectin diagnostic tests for inflammatory diseases of the bowel (HTG320, formerly DG11)
- World Gastroenterology Organisation. Global Guidelines: Irritable bowel syndrome
- South African Gastroenterology Society. WGO irritable bowel syndrome public education programme